Rohit Srivastava and Aravind Kumar of the Indian Institute of Technology, Bombay in India will develop a microneedle-based drug delivery system for the treatment of tuberculosis (TB). Current treatment involves frequent administration of combinations of toxic drugs, which often leads to non-compliance necessitating further complex treatments. They have designed a photo-thermosensitive nanocarrier based on liposomes that can release the drugs transdermally via microneedles upon exposure to sunlight or LED in a controlled manner, bypassing the need for multiple administrations and reducing toxic side effects. They will fabricate the microneedles, evaluate drug release dynamics using light, and test drug bioavailability in vivo using a small animal model. This grant was selected through India's IKP Knowledge Park and their IKP-GCE program.
More information about Grand Challenges Explorations - India